Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten's to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial).
Saved in:
| Title: | Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten's to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial). |
|---|---|
| Authors: | Wiegel T; Department of Radiotherapy and Radiation Oncology, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. thomas.wiegel@uniklinik-ulm.de., Albers P; Department of Urology, University Hospital Düsseldorf, Düsseldorf, Germany., Bartkowiak D; Department of Radiotherapy and Radiation Oncology, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany., Bussar-Maatz R; PREFERE Project Management, German Cancer Society, Berlin, Germany., Härter M; Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kristiansen G; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Martus P; Department of Clinical Epidemiology and Applied Biostatistics, University Hospital Tübingen, Tübingen, Germany., Wellek S; Department of Medical Biostatistics, Epidemiology and Informatics, University of Mainz, Mainz, Germany., Schmidberger H; Department of Radiotherapy and Radiation Oncology, University Hospital Mainz, Mainz, Germany., Grozinger K; Department of Urology, Klinikum Leverkusen, Leverkusen, Germany., Renner P; Center for Urology, Lübeck, Germany., Schneider F; Department of Urology, Klinikum Lippe Detmold, Detmold, Germany., Burmester M; Department of Urology, Vinzenzkrankenhaus, Hannover, Germany., Stöckle M; Department of Urology, University Hospital Homburg/Saar, Homburg, Germany. |
| Source: | Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2021 Apr; Vol. 147 (4), pp. 1273-1274. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33625578 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten's to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wiegel+T%22">Wiegel T</searchLink>; Department of Radiotherapy and Radiation Oncology, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. thomas.wiegel@uniklinik-ulm.de.<br /><searchLink fieldCode="AU" term="%22Albers+P%22">Albers P</searchLink>; Department of Urology, University Hospital Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Bartkowiak+D%22">Bartkowiak D</searchLink>; Department of Radiotherapy and Radiation Oncology, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Bussar-Maatz+R%22">Bussar-Maatz R</searchLink>; PREFERE Project Management, German Cancer Society, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Härter+M%22">Härter M</searchLink>; Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kristiansen+G%22">Kristiansen G</searchLink>; Institute of Pathology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Martus+P%22">Martus P</searchLink>; Department of Clinical Epidemiology and Applied Biostatistics, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Wellek+S%22">Wellek S</searchLink>; Department of Medical Biostatistics, Epidemiology and Informatics, University of Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Schmidberger+H%22">Schmidberger H</searchLink>; Department of Radiotherapy and Radiation Oncology, University Hospital Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Grozinger+K%22">Grozinger K</searchLink>; Department of Urology, Klinikum Leverkusen, Leverkusen, Germany.<br /><searchLink fieldCode="AU" term="%22Renner+P%22">Renner P</searchLink>; Center for Urology, Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Schneider+F%22">Schneider F</searchLink>; Department of Urology, Klinikum Lippe Detmold, Detmold, Germany.<br /><searchLink fieldCode="AU" term="%22Burmester+M%22">Burmester M</searchLink>; Department of Urology, Vinzenzkrankenhaus, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Stöckle+M%22">Stöckle M</searchLink>; Department of Urology, University Hospital Homburg/Saar, Homburg, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227902060%22">Journal of cancer research and clinical oncology</searchLink> [J Cancer Res Clin Oncol] 2021 Apr; Vol. 147 (4), pp. 1273-1274. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%22">Springer-Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7902060 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-1335 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201715216%22">01715216 </searchLink><i>NLM ISO Abbreviation: </i>J Cancer Res Clin Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33625578 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00432-021-03549-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1273 Titles: – TitleFull: Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten's to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wiegel T – PersonEntity: Name: NameFull: Albers P – PersonEntity: Name: NameFull: Bartkowiak D – PersonEntity: Name: NameFull: Bussar-Maatz R – PersonEntity: Name: NameFull: Härter M – PersonEntity: Name: NameFull: Kristiansen G – PersonEntity: Name: NameFull: Martus P – PersonEntity: Name: NameFull: Wellek S – PersonEntity: Name: NameFull: Schmidberger H – PersonEntity: Name: NameFull: Grozinger K – PersonEntity: Name: NameFull: Renner P – PersonEntity: Name: NameFull: Schneider F – PersonEntity: Name: NameFull: Burmester M – PersonEntity: Name: NameFull: Stöckle M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2021 Apr Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1432-1335 Numbering: – Type: volume Value: 147 – Type: issue Value: 4 Titles: – TitleFull: Journal of cancer research and clinical oncology Type: main |
| ResultId | 1 |
